Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$22.77
-3.72-14.04%
At close: Nov 14, 4:00 PM EST
$22.77
N/A
After Hours: Nov 14, 4:00 PM EST
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Neurogene (NGNE) stock?
You can purchase shares of Neurogene (NASDAQ:NGNE) through any online brokerage.
Who are Neurogene (NGNE) competitors?
Other companies in Neurogene’s space includes: Bright Minds Biosciences (NASDAQ:DRUG), Tectonic Therapeutic (NASDAQ:TECX), Galectin Therapeutics (NASDAQ:GALT), Immuneering (NASDAQ:IMRX) and Altimmune (NASDAQ:ALT).
What is the forecast, or price target, for Neurogene (NGNE) stock?
Neurogene has a consensus price target of $45.38.
What is the current price for Neurogene (NGNE)?
The stock price for Neurogene (NASDAQ: NGNE) is $22.77 last updated November 14, 2025 at 4:00 PM EST.
Does Neurogene (NGNE) pay a dividend?
There are no upcoming dividends for Neurogene.
When is Neurogene (NASDAQ:NGNE) reporting earnings?
Neurogene’s Q3 earnings are confirmed for Thursday, November 13, 2025.
Is Neurogene (NGNE) going to split?
There is no upcoming split for Neurogene.
What sector and industry does Neurogene (NGNE) operate in?
Neurogene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
